Keith McCrae is an Oncology physician affiliated with Cleveland Clinic. OpenAlex indexes 417 publications with 16,233 citations (h-index 64); ClinicalTrials.gov lists 8 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-8500Registry record last updated 29 Jan 2008.
Clinical trials
- Vascular Lab Resource (VLR) Biorepository
Sponsor: The Cleveland Clinic
- Pomalidomide for the Treatment of Bleeding in HHT
Sponsor: The Cleveland Clinic
- Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
Sponsor: The Cleveland Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year202510 payments
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- ARGENX US, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
13 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:
- Mechanisms of cancer immunotherapy-associated thrombosis
Cleveland Clinic Lerner Com-Cwru
FY2026$706,323R01HL164516 - Mechanisms of cancer immunotherapy-associated thrombosis
Cleveland Clinic Lerner Com-Cwru
FY2025$720,736R01HL164516 - Mechanisms of cancer immunotherapy-associated thrombosis
Cleveland Clinic Lerner Com-Cwru
FY2024$704,368R01HL164516
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival
Journal for ImmunoTherapy of Cancer
2021 - Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis
Journal of Clinical Investigation
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”